Deals
Boston Scientific Buys Endo Men’s Health Unit for $1.6 Billion
This article is for subscribers only.
Boston Scientific Corp. agreed to buy the American Medical Systems urology portfolio from Endo International Plc for at least $1.6 billion in cash to expand in men’s health and prostate treatments.
The purchase includes a potential additional $50 million milestone based on 2016 sales, Boston Scientific said in a statement on Monday. The businesses will become part of the Marlborough, Massachusetts-based company’s urology and women’s health arm.